NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

ACME Solar Shares See Healthy Upside Amid Market Weakness

ACME Solar Holdings shares have gained about 21% year-to-date (YTD) despite a weak stock market sentiment caused by the Middle East conflict, crude oil price hike, foreign capital outflow, and the rupee's fall to record low levels. The power stock has seen some profit booking lately, with a 5% decline in May so far after posting gains for the last three consecutive months. On Tuesday, 12 May, the ACME Solar share price declined more than 1% in intraday trade.

However, the ongoing correction in the stock price may present an opportunity to buy. Global brokerage firm HSBC and domestic brokerage firm Motilal Oswal Financial Services have both issued buy calls on the stock.

ACME Solar's Q4 numbers were largely on expected lines. The company's Q4FY26 Profit After Tax (PAT) rose by 12.93% year-on-year to ₹139.32 crore, while total income at ₹547.85 crore saw a healthy jump of 12.52% YoY. Operating profit increased by 15.95% to ₹370.38 crore, while operating margin climbed by 3.04% to 67.61%.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Brokerage FirmRecommendationTarget Price
HSBCBuy₹370
Motilal OswalBuy₹410

HSBC has a buy call on the stock, with a target price of ₹370. The global brokerage firm increased its target price from ₹350 on 8 May. HSBC believes that ACME Solar is in a high-growth phase, adding significant capacity over the next two years. The company is strategically evolving from a pure-play solar provider to a more complex firm and dispatchable renewable energy (DRE) projects, which require a combination of solar, wind, and battery storage capacity.

Motilal Oswal Financial Services also has a buy call on the stock with a target price of ₹410. The domestic brokerage firm has incorporated the merchant BESS capacity additions for FY27/FY28, resulting in a 6%/4% increase in its EBITDA estimates. Motilal said that the pace of commissioning against FY27 guidance of 1.5GW RE capacity addition, the progress of targeted 10GWh BESS capacity by end-FY27, and merchant spreads from BESS and their contribution to earnings in FY27 are the key monitorables for the stock.

However, some technical experts suggest that investors should wait for some more correction before initiating fresh long positions. ACME Solar has already witnessed a stellar rally over the last 2–3 months, and fresh long positions should be avoided at current levels. The stock is now showing signs of exhaustion near higher levels, which also aligns with the yearly pivot resistance zone. Moreover, RSI has formed a bearish divergence, indicating weakening momentum in the ongoing up move. On the downside, ₹275 will act as immediate support, while ₹306 remains the immediate resistance level.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Investor Takeaway

Investors may consider buying ACME Solar shares due to its strong Q4 numbers and analysts' positive predictions.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.